Cancer treatments represented 33 per cent of medicines in all phases of clinical trials in 2023, followed by treatments for infectious diseases (13 per cent) and central nervous system diseases (12 per cent), according to a new report by the Patented Medicine Prices Review Board. It found more than 12,000 new medicines were undergoing clinical […]
Hair — including eyelashes, eyebrows and body hair — protects the body from environmental factors such as temperature and also helps with how humans feel and sense things. In addition, people have a lot of their identity wrapped up in hair, said Dr. Kerri Purdy, a dermatologist, division head and associate professor at Dalhousie University […]
With chronic conditions growing in prevalence among plan members, plan sponsors have their work cut out for them in designing benefits plans that provide adequate health support and employee satisfaction while also being cost effective, said Marie-Hélène Dugal, manager of pharmacy benefit strategy for Medavie Blue Cross, during Benefits Canada’s 2023 Face to Face Drug […]
It’s important for private payers and employers to be nimble and innovative to support plan members seeking access to novel drugs and treatments by addressing common hurdles within their own drug plans, said John Adams, chair of the board of directors for patient advocacy group Best Medicines Coalition, during a session at Benefits Canada’s 2023 Face […]
The average cost of employer-sponsored health benefits in Canada is expected to decline to five per cent in 2024, down from 7.5 per cent in 2023, according to a report by Aon. The report, which is based on insights from more than 100 global Aon offices that broker, administer or advise on employer-sponsored medical plans, found […]